Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Surgical Care Affiliates, Inc. SCAI NASDAQ

NASDAQ • Healthcare • Health Care Equipment & Supplies • USD

SharesGrow Score
50/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Surgical Care Affiliates, Inc. (SCAI) is a Health Care Equipment & Supplies company in the Healthcare sector, currently trading at $55.87. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Financials: revenue is $1.3B, +17.1%/yr average growth. Net income is $35M, growing at +117.9%/yr. Net profit margin is 2.8% (thin). Gross margin is 100% (+0 pp trend).

Balance sheet: total debt is $1.1B against $440M equity (Debt-to-Equity (D/E) ratio 2.53, leveraged). Current ratio is 1.26 (adequate). Debt-to-assets is 41.8%. Total assets: $2.7B.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 90/100 (Pass), Past 75/100 (Partial), Health 33/100 (Fail), Moat 58/100 (Partial), Future ?/100 (Fail), Income 30/100 (Fail).

SCAI SharesGrow Score Overview

50/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 15/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 58/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SCAI

✗
VALUE Fail
15/100
SCAI trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
90/100
SCAI: +17.1%/yr revenue is, +117.9%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
SCAI: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet SCAI: Debt-to-Equity (D/E) ratio 2.53 (leveraged), Current ratio is 1.26 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
58/100
SCAI: Gross margin is 100% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
30/100
SCAI: Net profit margin is 2.8%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range57.44-37.51
Volume513.32K
Avg Volume (30D)365.04K
Beta (1Y)0.60
Share Statistics
EPS (TTM)0.88
Shares Outstanding$40.21M
IPO Date2016-01-04
Financial Highlights & Ratios
Revenue (TTM)$1.28B
Gross Profit$1.28B
EBITDA$197.34M
Net Income$35.45M
Operating Income$247.38M
Total Cash$360.01M
Total Debt$1.12B
Net Debt$983.71M
Total Assets$2.67B
Price / Earnings (P/E)63.5
Analyst Forecast
Company Info
ExchangeNASDAQ
CurrencyUSD

Price Chart

Track all markets on TradingView
SCAI
Surgical Care Affiliates, Inc.  ·  NASDAQ
Healthcare • Health Care Equipment & Supplies

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message